Classification of cell death: recommendations of the Nomenclature Committee on Cell Death
G Kroemer1, W S El-Deiry2, P Golstein3, M E Peter4, D Vaux5, P Vandenabeele6, B Zhivotovsky7, M V Blagosklonny8, W Malorni9, R A Knight10, M Piacentini11, S Nagata12 and G Melino10,13
1CNRS-UMR8125, Institut Gustave Roussy, 39 rue Camille-Desmoulins, F-94805 Villejuif, France
2University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
3Centre d'Immunologie INSERM/CNRS/Universite de la Mediterranee de Marseille-Luminy, Case 906, Avenue de Luminy, 13288 Marseille Cedex 9, France
4The Ben May Institute for Cancer Research, University of Chicago, 924 E 57th Street, Chicago, IL 60637, USA
5Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK
6Molecular Signalling and Cell Death Unit, Department for Molecular Biomedical Research, Flanders Interuniversity Institute for Biotechnology (VIB) and Ghent University, B9052 Ghent, Belgium
7Institute of Environmental Medicine, Karolinska Institutet, Box 210, Nobels vag 13, SE-171 77 Stockholm, Sweden
8Brander Cancer Research Institute, New York Medical College, 19 Bradhurst Avenue, Hawthorne, NY 10532, USA
9Istituto Superiore di Sanita, viale Regina Elena 299, I-00161 Rome, Italy
10Medical Research Council, Toxicology Unit, Leicester University, Leicester, UK
11Department Biology University Tor Vergata and Natl Inst. For Infectious Diseases 'L Spallanzani', Rome, Italy
12Department Genetics, Osaka University Medical School, Osaka, Japan
13IDI-IRCCS, c/o Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy
Correspondence: G Kroemer, CNRS-UMR 8125, Institut Gustave Roussy, Pavillon de Recherche 1, 39 rue Camille-Desmoulins, F-94805 Villejuif, France. Tel: +33-1-42-11-60-46; Fax: +33-1-42-11-60-47; E-mail: kroemer@igr.fr
Different cell death types are defined by morphological criteria, without a clear reference to precise biochemical mechanisms. The Nomenclature Committee on Cell Death (NCCD) proposes unified criteria for the definition of cell death and of different cell death morphologies, while formulating several caveats against the misuse of words and concepts that slow down progress in the area of cell death research. Nomenclature must be open to improvements and amendments to entail new discoveries, and the NCCD will help to update and clarify these points. Authors, reviewers and Editors of scientific periodicals are invited to abandon expressions like 'percentage apoptosis' and to replace them by more precise descriptions of the parameters that are actually measured. Moreover, at the present stage, it should be accepted that 'apoptosis', as a form of cell death, can occur with or without, caspase activation and that 'autophagic cell death' represents a type of cell death with (but not necessarily through) autophagic vacuolization. This article details the 2005 recommendations of NCCD. Over time, molecular definitions are expected to emerge for those forms of cell death that remain descriptive.
Preface
It is obvious that clear definitions of objects that are only shadows in Plato's cage are difficult to be achieved. Cell death and the different subroutines leading to cell death do not escape this rule. Even worse, the notion of death is strongly influenced by religious and cultural beliefs, which may subliminally influence the scientific view of cell death. As an example, it appears counterintuitive that some cells exert essential functions when they are 'dead' (such as erythrocytes and keratinocytes), and this underscores the importance of clearly defining what is referred to as 'cell death' as well as the multiple processes leading to it. Knowing that the meaning of scientific words changes when knowledge advances and that words, especially when they express changing concepts,1, 2, 3, 4 can increase confusion, one may adopt one of two opposing views. A significant fraction of the community of cell death researchers refutes nomenclature as an intellectual cage and as forever 'premature', remembering that many investigators desperately searched for 'DNA ladders' during the 1980s and 1990s. Indeed, such an alteration was thought to constitute the obligate manifestation of apoptosis, and reviewers and Editors often insisted that authors should discriminate between apoptosis and necrosis, based on this criterion (which nowadays has become somewhat obsolete). Some in the research community refute the preponderant idea that words can be used in a subjective fashion. Scientists simply should not behave as a Court of Justice confronted with the issue of pornography: the witness said that although he could not provide a clear definition of pornography, he knew what it was when he saw it. As a result of the need for more precise classification and following earlier discussions,5, 6 the Editors of Cell Death and Differentiation have created the NCCD, which formulated the following recommendations and caveats.
The NCCD suggests that it is important to discriminate between dying as a process and death as an end point. Dying can, of course, occur by several mechanisms, each characterized by a number of criteria, although not all need necessarily be present to satisfy the definition. It must be remembered that dying in a cell population is not a synchronous but rather a stochastic process, and that at a given time, individual cells will be at different stages of the dying process. This makes it all the more important to precisely define the criteria used to assess a dying population. It is not the intention of the NCCD to replace single terms in common usage with repeated cumbersome phrases like 'percentage of cells undergoing phosphatidylserine exposure'. Clearly, this would dramatically lengthen articles and presentations and may prove highly unpopular. Rather, the intention of the NCDD is to clearly define the available criteria used to evaluate a particular dying process. It is clear that as the field advances even more precise molecular definitions will likely emerge, and the nomenclature will need to be revised and updated. The NCCD suggests that more precise definitions will also serve a purpose to accelerate molecular understanding by demonstrating how much or how little we know about certain forms of cell death.
Top of pageRecommendation to Authors, Reviewers and Editors of Scientific Journals
Percentage apoptosis
As discussed above, authors frequently use expressions like 'percentage apoptosis' without mentioning the method used to assess ongoing cell death. Such expressions are confusing and imprecise and should be abandoned. Cell Death and Differentiation will actively enforce a policy in which expressions like 'percent apoptosis', 'percent necrosis', 'percent cell death' and 'percent cell survival' must be replaced by more descriptive terms such as 'percent cells with condensed chromatin', 'percent propidium iodine-positive'; 'percent annexin V-binding', 'percent active caspase-3 positive', 'percent TUNEL positive' cells, 'percent cells with DNA fragmentation', 'percent cells with a low mitochondrial transmembrane potential', or 'percent clone forming' cells. This applies to the description of experimental results, be it in the text or in the abstract, as well as to the labeling of figures and figure legends. The NCCD encourages investigators studying cell death to quantify this process using more than one assay whenever possible. This has been the general practice in the field by many, and it is hoped that over time specific criteria will emerge regarding what is necessary or sufficient to measure apoptosis or to predict death as an subsequent outcome based on any particular measurement.
Autophagy
Along the same lines, 'vesicular redistribution of LC3' or the 'presence of double-membraned microvesicles' (or whatever was actually observed) is better than 'autophagy'. Thus, rather than formalizing nomenclature, the use of functional terms should be encouraged as a general policy. The NCCD urges all life science journals and, more specifically, all journals in the areas of cell biology, cancer research and pharmacology to adopt a similar policy.
Top of pageWhen is a Cell 'Dead'?
Point-of-no-return
Dying cells can engage in a process that is reversible until a first irreversible step or 'point-of-no-return' is trespassed. It has been proposed that this step could be massive caspase activation, loss of the mitochondrial transmembrane potential (m),7 complete permeabilization of the outer mitochondrial membrane,8 or exposure of phosphatidylserine residues that emit 'eat me' signals to neighboring normal cells. However, there are examples in which caspases are activated in nonlethal activation and differentiation pathways. Moreover, the m can be dissipated by protonophores without that this would lead to immediate cell death.9 Finally, phosphatidylserine exposure can be reversible, for instance in neutrophilic granulocytes.10 Thus, the concept of a restriction point for cell death as was described by Pardee for the cell cycle has yet to be specifically defined for apoptosis.
Dead cells
In the absence of a clear, generally accepted view of the 'point-of-no-return', the NCCD suggests that a cell should be considered dead when any of the following molecular or morphological criteria are met: (1) the cell has lost the integrity of the plasma membrane, as defined by vital dyes in vitro; (2) the cell including its nucleus has undergone complete fragmentation into discrete bodies (which are frequently referred to as 'apoptotic bodies'); and/or (3) its corpse (or its fragments) have been engulfed by an adjacent cell in vivo. Thus, 'dead cells' would be different from bona fide 'dying cells' that are in the process of cell death, which can occur through a variety of different pathways (see below). Moreover, cells whose cell cycle is arrested (as it occurs in senescence) would be considered as alive and the expression 'replicative cell death' (which alludes to the loss of the clonogenic capacity) should be avoided.
Top of pageMechanism-based Definitions of Cell Death Types
It is evident that death may occur through different mechanisms leading to distinct morphologies. Consequently, different names have been coined. The NCCD strongly recommends a limit on new names except where specific molecular mechanisms, or at least pathognomonic morphological characteristics, have been defined.
G Kroemer1, W S El-Deiry2, P Golstein3, M E Peter4, D Vaux5, P Vandenabeele6, B Zhivotovsky7, M V Blagosklonny8, W Malorni9, R A Knight10, M Piacentini11, S Nagata12 and G Melino10,13
1CNRS-UMR8125, Institut Gustave Roussy, 39 rue Camille-Desmoulins, F-94805 Villejuif, France
2University of Pennsylvania School of Medicine, Philadelphia, PA 19104, USA
3Centre d'Immunologie INSERM/CNRS/Universite de la Mediterranee de Marseille-Luminy, Case 906, Avenue de Luminy, 13288 Marseille Cedex 9, France
4The Ben May Institute for Cancer Research, University of Chicago, 924 E 57th Street, Chicago, IL 60637, USA
5Sir William Dunn School of Pathology, University of Oxford, Oxford OX1 3RE, UK
6Molecular Signalling and Cell Death Unit, Department for Molecular Biomedical Research, Flanders Interuniversity Institute for Biotechnology (VIB) and Ghent University, B9052 Ghent, Belgium
7Institute of Environmental Medicine, Karolinska Institutet, Box 210, Nobels vag 13, SE-171 77 Stockholm, Sweden
8Brander Cancer Research Institute, New York Medical College, 19 Bradhurst Avenue, Hawthorne, NY 10532, USA
9Istituto Superiore di Sanita, viale Regina Elena 299, I-00161 Rome, Italy
10Medical Research Council, Toxicology Unit, Leicester University, Leicester, UK
11Department Biology University Tor Vergata and Natl Inst. For Infectious Diseases 'L Spallanzani', Rome, Italy
12Department Genetics, Osaka University Medical School, Osaka, Japan
13IDI-IRCCS, c/o Department of Experimental Medicine, University of Rome Tor Vergata, Rome, Italy
Correspondence: G Kroemer, CNRS-UMR 8125, Institut Gustave Roussy, Pavillon de Recherche 1, 39 rue Camille-Desmoulins, F-94805 Villejuif, France. Tel: +33-1-42-11-60-46; Fax: +33-1-42-11-60-47; E-mail: kroemer@igr.fr
Different cell death types are defined by morphological criteria, without a clear reference to precise biochemical mechanisms. The Nomenclature Committee on Cell Death (NCCD) proposes unified criteria for the definition of cell death and of different cell death morphologies, while formulating several caveats against the misuse of words and concepts that slow down progress in the area of cell death research. Nomenclature must be open to improvements and amendments to entail new discoveries, and the NCCD will help to update and clarify these points. Authors, reviewers and Editors of scientific periodicals are invited to abandon expressions like 'percentage apoptosis' and to replace them by more precise descriptions of the parameters that are actually measured. Moreover, at the present stage, it should be accepted that 'apoptosis', as a form of cell death, can occur with or without, caspase activation and that 'autophagic cell death' represents a type of cell death with (but not necessarily through) autophagic vacuolization. This article details the 2005 recommendations of NCCD. Over time, molecular definitions are expected to emerge for those forms of cell death that remain descriptive.
Preface
It is obvious that clear definitions of objects that are only shadows in Plato's cage are difficult to be achieved. Cell death and the different subroutines leading to cell death do not escape this rule. Even worse, the notion of death is strongly influenced by religious and cultural beliefs, which may subliminally influence the scientific view of cell death. As an example, it appears counterintuitive that some cells exert essential functions when they are 'dead' (such as erythrocytes and keratinocytes), and this underscores the importance of clearly defining what is referred to as 'cell death' as well as the multiple processes leading to it. Knowing that the meaning of scientific words changes when knowledge advances and that words, especially when they express changing concepts,1, 2, 3, 4 can increase confusion, one may adopt one of two opposing views. A significant fraction of the community of cell death researchers refutes nomenclature as an intellectual cage and as forever 'premature', remembering that many investigators desperately searched for 'DNA ladders' during the 1980s and 1990s. Indeed, such an alteration was thought to constitute the obligate manifestation of apoptosis, and reviewers and Editors often insisted that authors should discriminate between apoptosis and necrosis, based on this criterion (which nowadays has become somewhat obsolete). Some in the research community refute the preponderant idea that words can be used in a subjective fashion. Scientists simply should not behave as a Court of Justice confronted with the issue of pornography: the witness said that although he could not provide a clear definition of pornography, he knew what it was when he saw it. As a result of the need for more precise classification and following earlier discussions,5, 6 the Editors of Cell Death and Differentiation have created the NCCD, which formulated the following recommendations and caveats.
The NCCD suggests that it is important to discriminate between dying as a process and death as an end point. Dying can, of course, occur by several mechanisms, each characterized by a number of criteria, although not all need necessarily be present to satisfy the definition. It must be remembered that dying in a cell population is not a synchronous but rather a stochastic process, and that at a given time, individual cells will be at different stages of the dying process. This makes it all the more important to precisely define the criteria used to assess a dying population. It is not the intention of the NCCD to replace single terms in common usage with repeated cumbersome phrases like 'percentage of cells undergoing phosphatidylserine exposure'. Clearly, this would dramatically lengthen articles and presentations and may prove highly unpopular. Rather, the intention of the NCDD is to clearly define the available criteria used to evaluate a particular dying process. It is clear that as the field advances even more precise molecular definitions will likely emerge, and the nomenclature will need to be revised and updated. The NCCD suggests that more precise definitions will also serve a purpose to accelerate molecular understanding by demonstrating how much or how little we know about certain forms of cell death.
Top of pageRecommendation to Authors, Reviewers and Editors of Scientific Journals
Percentage apoptosis
As discussed above, authors frequently use expressions like 'percentage apoptosis' without mentioning the method used to assess ongoing cell death. Such expressions are confusing and imprecise and should be abandoned. Cell Death and Differentiation will actively enforce a policy in which expressions like 'percent apoptosis', 'percent necrosis', 'percent cell death' and 'percent cell survival' must be replaced by more descriptive terms such as 'percent cells with condensed chromatin', 'percent propidium iodine-positive'; 'percent annexin V-binding', 'percent active caspase-3 positive', 'percent TUNEL positive' cells, 'percent cells with DNA fragmentation', 'percent cells with a low mitochondrial transmembrane potential', or 'percent clone forming' cells. This applies to the description of experimental results, be it in the text or in the abstract, as well as to the labeling of figures and figure legends. The NCCD encourages investigators studying cell death to quantify this process using more than one assay whenever possible. This has been the general practice in the field by many, and it is hoped that over time specific criteria will emerge regarding what is necessary or sufficient to measure apoptosis or to predict death as an subsequent outcome based on any particular measurement.
Autophagy
Along the same lines, 'vesicular redistribution of LC3' or the 'presence of double-membraned microvesicles' (or whatever was actually observed) is better than 'autophagy'. Thus, rather than formalizing nomenclature, the use of functional terms should be encouraged as a general policy. The NCCD urges all life science journals and, more specifically, all journals in the areas of cell biology, cancer research and pharmacology to adopt a similar policy.
Top of pageWhen is a Cell 'Dead'?
Point-of-no-return
Dying cells can engage in a process that is reversible until a first irreversible step or 'point-of-no-return' is trespassed. It has been proposed that this step could be massive caspase activation, loss of the mitochondrial transmembrane potential (m),7 complete permeabilization of the outer mitochondrial membrane,8 or exposure of phosphatidylserine residues that emit 'eat me' signals to neighboring normal cells. However, there are examples in which caspases are activated in nonlethal activation and differentiation pathways. Moreover, the m can be dissipated by protonophores without that this would lead to immediate cell death.9 Finally, phosphatidylserine exposure can be reversible, for instance in neutrophilic granulocytes.10 Thus, the concept of a restriction point for cell death as was described by Pardee for the cell cycle has yet to be specifically defined for apoptosis.
Dead cells
In the absence of a clear, generally accepted view of the 'point-of-no-return', the NCCD suggests that a cell should be considered dead when any of the following molecular or morphological criteria are met: (1) the cell has lost the integrity of the plasma membrane, as defined by vital dyes in vitro; (2) the cell including its nucleus has undergone complete fragmentation into discrete bodies (which are frequently referred to as 'apoptotic bodies'); and/or (3) its corpse (or its fragments) have been engulfed by an adjacent cell in vivo. Thus, 'dead cells' would be different from bona fide 'dying cells' that are in the process of cell death, which can occur through a variety of different pathways (see below). Moreover, cells whose cell cycle is arrested (as it occurs in senescence) would be considered as alive and the expression 'replicative cell death' (which alludes to the loss of the clonogenic capacity) should be avoided.
Top of pageMechanism-based Definitions of Cell Death Types
It is evident that death may occur through different mechanisms leading to distinct morphologies. Consequently, different names have been coined. The NCCD strongly recommends a limit on new names except where specific molecular mechanisms, or at least pathognomonic morphological characteristics, have been defined.


